Researchers are continuously working on identifying other molecular targets in stomach cancer cells to develop more effective targeted therapies.Immunotherapy has revolutionized the field of cancer treatment, and stomach cancer is no exception. Immune checkpoint inhibitors, such as pembrolizumab and nivolumab, have shown promising results in advanced or metastatic gastric cancer. Stomach Cancer Drugs work by blocking the proteins that prevent immune cells from attacking cancer cells, thus boosting the body's natural defense mechanisms against the disease.

The use of immunotherapy in combination with chemotherapy or targeted therapy has further improved treatment outcomes in select patient populations. Chemotherapy remains a crucial component of Stomach Cancer Drugs, particularly for patients with advanced or unresectable disease. Several drugs, such as cisplatin, oxaliplatin, and fluorouracil, are commonly used in combination regimens to inhibit cancer cell growth and shrink tumors. Recent research has focused on optimizing chemotherapy regimens by tailoring them to the individual patient's characteristics, such as tumor subtype and genetic profile.

Read More @ http://cmiblogpost.weebly.com/article/stomach-cancer-drugs-help-in-pre-and-post-surgeries